The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group
Abstract
To cite this article: Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B on behalf of HAWK (H ereditary A ngioedema International W or k ing Group). Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 2012; 67: 147–157. Angioedema owing to hereditary deficiency of C1 inhibitor (HAE) is a rare, life‐threatening, disabling disease. In the last 2 years, the results of well‐designed and controlled trials with existing and new therapies for this condition have been published, and new treatments reached the market. Current guidelines for the treatment for HAE were released before the new trials and before the new treatments became available and were essentially based on observational studies and expert opinion. To provide evidence‐based HAE treatment guidelines supported by the new studies, a conference was held in Gargnano del Garda, Italy, from September 26 to 29, 2010. The meeting hosted 58 experienced HAE expert physicians, representatives of pharmaceutical companies and representatives of HAE patients’ associations. Here, we report the topics discussed during the meeting and evidence‐based consensus about management approaches for HAE in adult/adolescent patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Zuraw, B. L. (2008) · New England Journal of Medicine · doi:10.1056/nejmcp0803977 · Cited by 693
Self-citationAgostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
Self-citationHereditary Angioedema: the Clinical Syndrome and Its Management
FRANK, M. M., GELFAND, J. A., & ATKINSON, J. P. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-5-580 · Cited by 615
Bowen, T., Cicardi, M., Farkas, H., Bork, K., Longhurst, H. J., Zuraw, B., Aygoeren-Pürsün, E., Craig, T., Binkley, K., Hebert, J., et al. (2010) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-6-24 · Cited by 614
Self-citationAGOSTONI, A., & CICARDI, M. (1992) · Medicine · doi:10.1097/00005792-199207000-00003 · Cited by 610
Self-citationTreatment of Hereditary Angioedema with Danazol: Reversal of Clinical and Biochemical Abnormalities
Gelfand, J. A., Sherins, R. J., Alling, D. W., & Frank, M. M. (1976) · New England Journal of Medicine · doi:10.1056/nejm197612232952602 · Cited by 607
Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
Cicardi, M., Banerji, A., Bracho, F., Malbrán, A., Rosenkranz, B., Riedl, M., Bork, K., Lumry, W., Aberer, W., Bier, H., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0906393 · Cited by 564
Self-citationC1 inhibitor deficiency: consensus document
Gompels, M. M., Lock, R. J., Abinun, M., Bethune, C. A., Davies, G., Grattan, C., Fay, A. C., Longhurst, H. J., Morrison, L., Price, A., et al. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02726.x · Cited by 411
Self-citationTreatment of Hereditary Angioedema with a Vapor-Heated C1 Inhibitor Concentrate
Waytes, A. T., Rosen, F. S., & Frank, M. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606203342503 · Cited by 321
Ecallantide for the Treatment of Acute Attacks in Hereditary Angioedema
Cicardi, M., Levy, R. J., McNeil, D. L., Li, H. H., Sheffer, A. L., Campion, M., Horn, P. T., & Pullman, W. E. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905079 · Cited by 312
Self-citationHaynes, R. B. (2002) · BMC Health Services Research · doi:10.1186/1472-6963-2-3 · Cited by 296
Epsilon Aminocaproic Acid Therapy of Hereditary Angioneurotic Edema: A Double-Blind Study
Frank, M. M., Sergent, J. S., Kane, M. A., & Alling, D. W. (1972) · New England Journal of Medicine · doi:10.1056/nejm197204132861503 · Cited by 272
Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients
Bork, K., Bygum, A., & Hardt, J. (2008) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)60424-3 · Cited by 228
Self-citationZuraw, B., Cicardi, M., Levy, R. J., Nuijens, J. H., Relan, A., Visscher, S., Haase, G., Kaufman, L., & Hack, C. E. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.021 · Cited by 219
Self-citationBork, K., Frank, J., Grundt, B., Schlattmann, P., Nussberger, J., & Kreuz, W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.012 · Cited by 200
Self-citationBowen, T., Cicardi, M., Farkas, H., Bork, K., Kreuz, W., Zingale, L., Varga, L., Martinez-Saguer, I., Aygören-Pürsün, E., Binkley, K., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.043 · Cited by 185
Self-citationGrundt, B., Bork, K., Frank, J., Schlattmann, P., Nussberger, J., Rosenkranz, B., Dong, L., Knolle, J., & Kreuz, W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.459 · Cited by 167
Self-citationCicardi, M., Castelli, R., Zingale, L. C., & Agostoni, A. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70095-2 · Cited by 162
Self-citationKunschak, M., Engl, W., Maritsch, F., et al. (1998) · Transfusion · doi:10.1046/j.1537-2995.1998.38698326333.x · Cited by 147
Czaller, I., Visy, B., Csuka, D., Füst, G., Tóth, F., & Farkas, H. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.05.008 · Cited by 141
Bork, K., Meng, G., Staubach, P., & Hardt, J. (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.00602.x · Cited by 139
Self-citationSchneider, L. C., Lumry, W. R., Vegh, A. B., Williams, A. H., & Schmalbach, T. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.028 · Cited by 128
Management of Hereditary Angioedema in Pediatric Patients
Farkas, H., Varga, L. Á., Széplaki, G., Visy, B., Harmat, G., & Bowen, T. (2007) · PEDIATRICS · doi:10.1542/peds.2006-3303 · Cited by 121
Serres, J. D., Gröner, A., & Lindner, J. K. (2003) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2003.08.006 · Cited by 108
IMRIE, C. W., & Blumgart, L. H. (1975) · The Lancet · doi:10.1016/s0140-6736(75)91523-8 · Cited by 78
Treatment of skin swellings with C1‐inhibitor concentrate in patients with hereditary angio‐oedema
Bork, K., Staubach, P., & Hardt, J. (2008) · Allergy · doi:10.1111/j.1398-9995.2007.01577.x · Cited by 68
Self-citationLehmann, A. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.8.1187 · Cited by 66
Farkas, H., Czaller, I., Csuka, D., Vas, A., Valentin, S., Varga, L. Á., Széplaki, G., Jakab, L., Füst, G., Prohászka, Z., et al. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0771-z · Cited by 52
Birjmohun, R., Hovingh, G., Stroes, E., Hofstra, J. J., Dallinga-Thie, G., Meijers, J., Kastelein, J., & Levi, M. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.12.021 · Cited by 51
Therapeutic potential of icatibant (HOE-140, JE-049)
Cruden, N. L. M., & Newby, D. E. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.13.2383 · Cited by 37
Management of acute attacks of hereditary angioedema: potential role of icatibant
Longhurst, H. J. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4332 · Cited by 36
Self-citationSzegedi, R., Széplaki, G., Varga, L. Á., Prohászka, Z., Széplaki, Z., Karádi, I., Füst, G., & Farkas, H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.025 · Cited by 35
The role of evidence‐based medicine and clinical trials in rare genetic disorders
Kruer, M. C., & Steiner, R. D. (2008) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01041.x · Cited by 27
Cited by
Cicardi, M., Aberer, W., Banerji, A., Bas, M., Bernstein, J. A., Bork, K., Caballero, T., Farkas, H., Grumach, A., Kaplan, A. P., et al. (2014) · Allergy · doi:10.1111/all.12380 · Cited by 666
Self-citationMaurer, M., Magerl, M., Betschel, S., Aberer, W., Ansotegui, I. J., Aygören‐Pürsün, E., Banerji, A., Bara, N., Boccon‐Gibod, I., Bork, K., et al. (2022) · Allergy · doi:10.1111/all.15214 · Cited by 534
Self-citationDiabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Maurer, M., Magerl, M., Ansotegui, I., Aygören‐Pürsün, E., Betschel, S., Bork, K., Bowen, T., Balle Boysen, H., Farkas, H., Grumach, A. S., et al. (2018) · Allergy · doi:10.1111/all.13384 · Cited by 513
Self-citationWAO Guideline for the Management of Hereditary Angioedema
Craig, T., Pürsün, E. A., Bork, K., Bowen, T., Boysen, H., Farkas, H., Grumach, A., Katelaris, C. H., Lockey, R., Longhurst, H., et al. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e318279affa · Cited by 346
Self-citation
Metadata
- Authors
- Cicardi, M., Bork, K., Caballero, T., Craig, T., Li, H. H., Longhurst, H., Reshef, A., Zuraw, B., & on behalf of HAWK (Hereditary Angioedema International Working Group)
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2011-11-30
- Volume
- 67
- Issue
- 2
- Pages
- 147-157
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2118852493
- Cited by
- 349
- References
- 34
- FWCI
- 19.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.